<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A characteristic alkaline phosphatase (orthophosphoric monoester hydrolase, alkaline pH optimum, EC 3.1.3.1) was detected in the sera of most patients with <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_339'>lymphatic leukaemia</z:mpath>, non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The enzyme was also present in the sera of nine out of 26 patients with <z:e sem="disease" ids="C0302592,C0007847" disease_type="Neoplastic Process" abbrv="">cancer of the cervix</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>N-APase in these cases counted 30-100% of the total alkaline phosphatase activity </plain></SENT>
<SENT sid="3" pm="."><plain>N-APase was absent from the sera of healthy individuals and of patients with <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_338'>granulocytic leukaemia</z:mpath>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, <z:e sem="disease" ids="C0024141" disease_type="Disease or Syndrome" abbrv="">systemic lupus erythematosis</z:e>, <z:hpo ids='HP_0012115'>hepatitis</z:hpo> and obstructive <z:hpo ids='HP_0000952'>jaundice</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Only three of 22 patients with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> showed n-apase activity in the serum </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> the presence of N-APase activity was well correlated with the clinical course </plain></SENT>
<SENT sid="6" pm="."><plain>In 13 cases studied, the clinical improvement was associated with the decrease or disappearance of N-APase activity </plain></SENT>
<SENT sid="7" pm="."><plain>N-APase activity could not be detected in white cells of <z:hpo ids='HP_0011009'>acute</z:hpo> myeloid leukaemic patients, nor in the cells of myeloid blastic crisis of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_338'>granulocytic leukaemia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>It was present in the cells of lymphoid blastic crisis of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_338'>granulocytic leukaemia</z:mpath> </plain></SENT>
</text></document>